Status:

COMPLETED

Efficacy of Achieving Early Target Trough Levels of Tacrolimus Using CYP3A5 Guided Dosing Versus Weight-based Dosing in a Multi-ethnic Population of Kidney Transplant Recipients in Singapore

Lead Sponsor:

Singapore General Hospital

Conditions:

Kidney Transplant Rejection

Kidney Transplant; Complications

Eligibility:

All Genders

21-75 years

Phase:

NA

Brief Summary

The investigators hypothesise that the adaptation of CYP3A5 genotype-based Tacrolimus (FK) dosing will lead to earlier FK target achievement and consequently, better clinical outcome after kidney tran...

Detailed Description

Tacrolimus (FK) remains the cornerstone of maintenance immunosuppressants after renal transplantation. However, it is characterised by narrow therapeutic index and large inter-individual variability i...

Eligibility Criteria

Inclusion

  • On follow up at SGH between the ages of 21 and 75 years old who had received or are scheduled to receive a living donor renal transplant between January 2016 to January 2023
  • Has to receive tacrolimus (FK) (Prograf®; Astellas Pharma, Singapore), mycophenolic acid (MPA) (Cellcept®; Roche, Basel, Switzerland or Myfortic®; Novartis Pharma AG, Basel, Switzerland) and prednisolone as triple immunosuppressive drug maintenance regimen

Exclusion

  • Planned to be initiated on non-standard doses of tacrolimus (e.g. planned to initiate on sub-therapeutic doses of tacrolimus)
  • Evidence of active liver disease or gastrointestinal disorder that might interfere with the ability to absorb oral medication
  • Contraindications to tacrolimus (FK) - e.g. hypersensitivity
  • Takes concurrent medications which are known to severely interact with FK (e.g. verapamil, azoles, rifampicin, erythromycin or clarithromycin

Key Trial Info

Start Date :

February 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 9 2024

Estimated Enrollment :

74 Patients enrolled

Trial Details

Trial ID

NCT04825262

Start Date

February 1 2021

End Date

April 9 2024

Last Update

November 13 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Singapore General Hospital

Singapore, Singapore, 767972